Tactile Systems Technology (TCMD) Net Cash Flow Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -562.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -564.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 76.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -31.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -394.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 57.36% |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn | 21.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.35% |
| Dec 31, 2025 | 43.04% |
| Sep 30, 2025 | -282.49% |
| Jun 30, 2025 | -116.19% |
| Mar 31, 2025 | -3,186.85% |
| Dec 31, 2024 | 344.27% |
| Sep 30, 2024 | 201.98% |
| Jun 30, 2024 | 57.44% |
| Mar 31, 2024 | -100.99% |
| Dec 31, 2023 | -234.20% |
| Sep 30, 2023 | 3,615.79% |
| Jun 30, 2023 | 272.77% |
| Mar 31, 2023 | 567.33% |
| Dec 31, 2022 | -125.69% |
| Sep 30, 2022 | 100.29% |
| Jun 30, 2022 | 5.67% |
| Mar 31, 2022 | -661.18% |
| Dec 31, 2021 | 3.13% |
| Sep 30, 2021 | -344.92% |
| Jun 30, 2021 | 317.78% |
| Mar 31, 2021 | -109.76% |
| Dec 31, 2020 | 91.17% |
| Sep 30, 2020 | 307.86% |
| Jun 30, 2020 | -164.08% |
| Mar 31, 2020 | 176.22% |
| Dec 31, 2019 | 197.33% |
| Sep 30, 2019 | -189.86% |
| Jun 30, 2019 | 118.67% |
| Mar 31, 2019 | 156.43% |
| Dec 31, 2018 | -170.38% |
| Sep 30, 2018 | 273.54% |
| Jun 30, 2018 | -205.31% |
| Mar 31, 2018 | 113.47% |
| Dec 31, 2017 | 150.22% |
| Sep 30, 2017 | -95.22% |
| Jun 30, 2017 | -380.90% |
| Mar 31, 2017 | -684.52% |
| Dec 31, 2016 | -719.09% |
| Sep 30, 2016 | 5,910.15% |